Kronos Bio, Inc.
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks th…
Biotechnology
US, San Mateo [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Kronos Bio, Inc. (KRON) to it's peer group.
Peer Group
CRNX CTMX NXTC CYCN LYEL GOSS CCCC GBIO SPRO LRMR NLTX EWTX INBX NVCT ERAS ASMB REPL LYRA
Compare Together
Loading...